Program length (60 minutes)
- Welcome and Introduction
- Case-Based Presentation
- Discussion and Audience Question and Answer Session
Date / Time
Martin J. Abrahamson, MD
Associate Professor of Medicine
Harvard Medical School
Director, Division of CME, Beth Israel Medical Center
Beth Israel Deaconess Medical Center
Anne Peters, MD
Director, USC Clinical Diabetes Program
Professor of Clinical Medicine
Keck School of Medicine of USC
Los Angeles, California
The goal of this activity is to improve the competence of primary care physicians, nurse practitioners, physician assistants, and other members of the healthcare team in managing type 2 diabetes.
This program is intended for primary care providers; physicians, nurse practitioners, physician assistants, as well as the diabetes patients under their care.
Upon completion of this activity, participants should be able to:
- Examine the evidence that supports the use of GLP-1 RA products in patients with T2D regarding their impact on weight and CV risk
- Summarize the latest findings on renal outcomes from recent studies of GLP-1 RA products and implications for drug selection in patients at increased risk for nephropathy due to T2D
- Differentiate the pharmacokinetic and pharmacodynamic characteristics of long-acting injection and emerging oral GLP-1 RA products and how to optimize their use early in the T2D disease course
- Explore strategies to help patients prevent or overcome gastrointestinal adverse events and to improve rates of adherence with GLP-1 RA therapy
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this activity is 1.0 contact hour.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.